Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
, 16 (6), 502-513

Efficacy of Platelet-Rich Plasma as Conservative Treatment in Orthopaedics: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Efficacy of Platelet-Rich Plasma as Conservative Treatment in Orthopaedics: A Systematic Review and Meta-Analysis

Massimo Franchini et al. Blood Transfus.

Abstract

Background: The aim of this systematic review and meta-analysis was to evaluate the benefit of platelet-rich plasma (PRP) in non-surgical orthopaedic procedures.

Material and methods: We searched the Cochrane Wounds Specialized Register, CENTRAL, MEDLINE (through PUBMED), Embase, and SCOPUS. We also searched clinical trials registries for ongoing and unpublished studies and checked reference lists to identify additional studies.

Results: We found 36 randomised controlled trials (2,073 patients) that met our inclusion criteria. The included studies mostly had small numbers of participants (from 20 to 225). Twenty-eight studies included patients with lateral epicondylitis or plantar fasciitis. PRP was compared to local steroids injection (19 studies), saline injection (6 studies), autologous whole blood (4 studies), local anaesthetic injection (3 studies), dry needling injection (3 studies), and to other comparators (4 studies). Primary outcomes were pain and function scores, and adverse events. On average, it is unclear whether or not use of PRP compared to controls reduces pain scores and functional score at short- (up to 3 months) and medium- (4-6 months) term follow-up. The available evidence for all the comparisons was rated as very low quality due to inconsistency, imprecision, and risk of bias in most of the selected studies. There were no serious adverse events related to PRP injection or control treatments.

Conclusions: The results of this meta-analysis, which documents the very marginal effectiveness of PRP compared to controls, does not support the use of PRP as conservative treatment in orthopaedics.

Conflict of interest statement

Disclosure of conflicts of interest

GML is the Editor-in-Chief of Blood Transfusion and this manuscript has undergone additional external review as a result. The other Authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of the inclusion of the studies. RCT: randomised controlled clinical trials.
Figure 2
Figure 2
A) Risk of bias graph and (B) summary. PRP: Platelet-rich plasma; SD: standard deviation; IV: intravenous; CI: Confidence Interval.
Figure 3
Figure 3
Forest plot of Visual Analogue Score (VAS) at 3 months..
Figure 4
Figure 4
Forest plot of Visual Analogue Score (VAS) at 6 months.

Comment in

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles
Feedback